Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Max van Noesel

Clinical director Solid tumors
Dr. Max van Noesel is pediatric oncologist and scientist. Together with prof. dr. Jan Molenaar he focuses on the development of better treatment options for children with neuroblastoma.
  • Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition

    • dec. 2025
    • Femke C.A.S., Ringnalda, et al
    • Nature communications
  • γδ T cells are the prime antitumoral T cells in pediatric neuroblastoma

    • nov. 2025
    • Suzanne M., Castenmiller, et al
    • Life science alliance
  • Surgical Lymph Node Staging in Extremity Rhabdomyosarcoma

    • okt. 2025
    • Sheila, Terwisscha van Scheltinga, et al
    • Annals of surgical oncology
  • Accelerating Drug Development for Neuroblastoma

    • sep. 2025
    • Steven G., DuBois, et al
    • Pediatric Blood and Cancer
  • SUV normalisation and reference tissue selection for [<sup>1</sup>⁸F]mFBG PET-CT in paediatric and adult patients

    • aug. 2025
    • Atia, Samim, et al
    • European journal of nuclear medicine and molecular imaging
View all publications